Sign in
4

Changes in Ownership

Damora Therapeutics, Inc. Filed Acc 0000899243-20-030414

Director bought 733,333 shares at $15.00 ($10,999,995)

  • Director acquired 3,069,922 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
ORBIMED ADVISORS LLC Director 2020-11-02 Conversion +2,055,824 2,055,824 I
ORBIMED ADVISORS LLC Director 2020-11-02 Conversion +822,311 822,311 I
ORBIMED ADVISORS LLC Director 2020-11-02 Conversion +191,787 191,787 I
ORBIMED ADVISORS LLC Director 2020-11-02 Purchase +523,833 $15.00 $7,857,495 2,579,657 I
ORBIMED ADVISORS LLC Director 2020-11-02 Purchase +209,500 $15.00 $3,142,500 1,031,811 I
Derivatives
ORBIMED ADVISORS LLC Director 2020-09-25 Grant or award · Series D Preferred Stock −148,395 $27.11 $4,022,988 148,395 I
ORBIMED ADVISORS LLC Director 2020-09-25 Grant or award · Series D Preferred Stock −59,350 $27.11 $1,608,979 59,350 I
ORBIMED ADVISORS LLC Director 2020-09-25 Grant or award · Series D Preferred Stock −73,773 $27.11 $1,999,986 73,773 I
ORBIMED ADVISORS LLC Director 2020-11-02 Conversion · Series C-2 Preferred Stock −291,999 0 I
ORBIMED ADVISORS LLC Director 2020-11-02 Conversion · Series C-2 Preferred Stock −116,800 0 I
ORBIMED ADVISORS LLC Director 2020-11-02 Conversion · Series C-4 Preferred Stock −272,533 0 I
ORBIMED ADVISORS LLC Director 2020-11-02 Conversion · Series C-4 Preferred Stock −109,013 0 I
ORBIMED ADVISORS LLC Director 2020-11-02 Conversion · Series C-5 Preferred Stock −77,866 0 I
ORBIMED ADVISORS LLC Director 2020-11-02 Conversion · Series C-5 Preferred Stock −31,147 0 I
ORBIMED ADVISORS LLC Director 2020-11-02 Conversion · Series D Preferred Stock −148,395 0 I
ORBIMED ADVISORS LLC Director 2020-11-02 Conversion · Series D Preferred Stock −59,350 0 I
ORBIMED ADVISORS LLC Director 2020-11-02 Conversion · Series D Preferred Stock −73,773 0 I
Open-market purchases · 733,333 sh · avg $15.00 · $10,999,995
Loading xslF345X03/doc4.xml…